4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-017030
Director acquired 6,407 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krogulski Kenneth Director | 2023-12-01 | Other acquisition 10b5-1 | +379 | $1.69 | $641 | 230,249 | D |
| Krogulski Kenneth Director | 2023-12-04 | Other acquisition 10b5-1 | +322 | $1.72 | $554 | 230,571 | D |
| Krogulski Kenneth Director | 2023-12-05 | Other acquisition 10b5-1 | +379 | $1.69 | $641 | 230,950 | D |
| Krogulski Kenneth Director | 2023-12-06 | Other acquisition 10b5-1 | +379 | $1.70 | $644 | 231,329 | D |
| Krogulski Kenneth Director | 2023-12-07 | Other acquisition 10b5-1 | +174 | $1.65 | $287 | 231,503 | D |
| Krogulski Kenneth Director | 2023-12-08 | Other acquisition 10b5-1 | +379 | $1.83 | $694 | 231,882 | D |
| Krogulski Kenneth Director | 2023-12-11 | Other acquisition 10b5-1 | +434 | $1.85 | $803 | 232,316 | D |
| Krogulski Kenneth Director | 2023-12-12 | Other acquisition 10b5-1 | +456 | $1.77 | $807 | 232,772 | D |
| Krogulski Kenneth Director | 2023-12-13 | Other acquisition 10b5-1 | +434 | $1.80 | $781 | 233,206 | D |
| Krogulski Kenneth Director | 2023-12-14 | Other acquisition 10b5-1 | +434 | $1.86 | $807 | 233,640 | D |
| Krogulski Kenneth Director | 2023-12-15 | Other acquisition 10b5-1 | +434 | $1.89 | $820 | 234,074 | D |
| Krogulski Kenneth Director | 2023-12-18 | Other acquisition 10b5-1 | +407 | $1.80 | $733 | 234,481 | D |
| Krogulski Kenneth Director | 2023-12-19 | Other acquisition 10b5-1 | +407 | $1.73 | $704 | 234,888 | D |
| Krogulski Kenneth Director | 2023-12-20 | Other acquisition 10b5-1 | +628 | $1.76 | $1,105 | 235,516 | D |
| Krogulski Kenneth Director | 2023-12-21 | Other acquisition 10b5-1 | +761 | $1.70 | $1,294 | 236,277 | D |
Loading xslF345X05/marketforms-63935.xml…